Carmen Álvarez‐Navascués

Author

Hospital Universitario Central de Asturias ORCID

Also Known As

C. Alvarez-Navascues, C. Álvarez-Navascués, Carmen Alvarez-Navascués, Carmen Álvarez Navascués, Carmen Álvarez-Navascues, Carmen Álvarez-Navascués, Carmen Álvarez-Navascúes, Carmen Álvarez‐Navascués, Carmen Álvarez‐Navascúes, Ãlvarez-NavascuÃ©s,Carmen

Publications

454

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Central de Asturias Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Universitat Autònoma de Barcelona Instituto de Salud Carlos III Hospital General Universitario Gregorio Marañón

CÁ

About

Carmen Álvarez‐Navascués is an author at Hospital Universitario Central de Asturias specializing in hepatology, medicine, and liver transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	197
2	Hepatology	3	3	197
3	Health Sciences	1	1	29
4	Gastroenterology	1	1	24
5	Microbiology	1	1	29

Carmen Álvarez‐Navascués

Publications

399

Citations

H-Index

Page 1

	Year	Citations
Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study Anna Baiges, Fanny Turón, Macarena Simón‐Talero, Hepatology Abernethy MalformationCongenital ShuntShunt ClosureHepatologyPediatrics	2019	144
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration Álvaro Díaz‐González, Manuel Hernández‐Guerra, Indhira Pérez‐Medrano, Hepatology	2023	47
Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis Manuel Rodríguez, M.L. González-Diéguez, Marı́a Varela, The American Journal of Gastroenterology	2021	41
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study A. Reig, Carmen Álvarez‐Navascués, Mercedes Vergara, The American Journal of Gastroenterology	2021	34
Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome Marta Magaz, Heloïse Giudicelli-Lett, Oana Nicoară-Farcău, Transplantation	2022	32
Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors Rosa Martín‐Mateos, Laura Martínez‐Arenas, Ângela Carvalho‐Gomes, Journal of Hepatology Multidrug-resistant Bacterial InfectionsAntimicrobial SusceptibilityHepatologyAntibioticsHealth Sciences	2024	29
Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The CARDIO‐SOR study Lorena Carballo‐Folgoso, Rut Álvarez‐Velasco, Rebeca Lorca, Liver International	2021	24
Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial Ángela Puente Sánchez, Fanny Turón, Javier Martínez, Journal of Hepatology Moderate Liver DysfunctionHepatologyGastrointestinal PharmacologyLiver PhysiologyRivaroxaban Improves Survival	2023	24
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the <scp>ColHai</scp> registry Mar Riveiro‐Barciela, Ana Barreira‐Díaz, Paula Esteban García, Liver International	2024	24

Page 1